60 filings
8-K
TPTX
Turning Point Therapeutics, Inc.
17 Aug 22
Termination of a Material Definitive Agreement
8:44am
8-K
TPTX
Turning Point Therapeutics, Inc.
8 Aug 22
Turning Point Therapeutics Reports Second-quarter 2022 Financial Results, Provides Operational Updates
4:18pm
8-K
TPTX
Turning Point Therapeutics, Inc.
24 Jun 22
Entry into a Material Definitive Agreement
9:01am
8-K
TPTX
Turning Point Therapeutics, Inc.
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
TPTX
Turning Point Therapeutics, Inc.
3 Jun 22
Entry into a Material Definitive Agreement
5:15pm
8-K
dnnonm0ao927ejx4y
3 Jun 22
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
9:00am
8-K
etyoyv2
10 May 22
Turning Point Therapeutics Reports First-quarter 2022 Financial Results, Provides Operational Updates
12:00am
8-K
w3mn3hz
5 May 22
Entry into a Material Definitive Agreement
9:01am
8-K
2qzsl duby79
13 Apr 22
Other Events
8:00am
8-K
w9602cc2
4 Mar 22
Departure of Directors or Certain Officers
4:06pm
8-K
ndtz 9ud75
28 Feb 22
Turning Point Therapeutics Reports Fourth-quarter and Full Year 2021 Financial Results, Provides Operational Updates
4:14pm
8-K
5wtz1q
18 Feb 22
Departure of Directors or Certain Officers
4:08pm
8-K
88ye3 box
18 Jan 22
Turning Point Therapeutics Provides Updates and Anticipated 2022 Clinical and Discovery Pipeline Milestones
9:05am
8-K
rwj axvza9n
9 Nov 21
Turning Point Therapeutics Reports Third-quarter Financial Results, Provides Operational Updates
4:03pm
8-K
qpj mgvkh
13 Oct 21
Entry into a Material Definitive Agreement
4:16pm
8-K
bb7a5nazia
8 Oct 21
Other Events
8:35am
8-K
y7vly9w1qhljv5o hm
7 Oct 21
Other Events
7:06am
8-K
88ocx
9 Aug 21
Turning Point Therapeutics Reports Second-quarter Financial Results, Provides Operational Updates
4:06pm
8-K
rmew9l5 xv3an6s
29 Jun 21
Departure of Directors or Certain Officers
9:10am
8-K
rmr8pu5kf epad
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm